Ambu A/S (OTCMKTS:AMBBY) Releases Quarterly Earnings Results

Key Points

• Ambu A/S reported quarterly earnings of $0.07 EPS, with a net margin of 8.86% and a return on equity of 9.15%.
• Shares fell about 6.3% to $9.98 on Wednesday; the company has a market cap of $2.35 billion, a price‑to‑earnings ratio of 32.19, and a 52‑week range of $9.70–$16.78.
• Ambu is a Denmark‑based medical‑device company specializing in single‑use anesthesia, respiratory care and endoscopy products, best known for disposable “Ambu bags” and airway‑management devices.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.07 EPS for the quarter, Zacks reports. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%.

Ambu A/S Trading Down 6.3%

OTCMKTS:AMBBY traded down $0.67 during trading hours on Wednesday, reaching $9.98. 600 shares of the company were exchanged, compared to its average volume of 159. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67. The firm has a market cap of $2.35 billion, a price-to-earnings ratio of 32.19 and a beta of 1.06. Ambu A/S has a 52-week low of $9.70 and a 52-week high of $16.78. The stock has a 50 day simple moving average of $10.91 and a 200 day simple moving average of $12.78.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.